04.13.18
Dr. Jin Wang has been appointed site head/general manager of AGC Biologics’ Bothell, WA operations. Ms. Wang will provide leadership and site management for the company’s contract development and manufacturing services. Dr. Wang will report to Patricio Massera, chief operations officer.
Dr. Wang has more than 20 years of leadership experience in the biotechnology and manufacturing industry. Most recently she served as site head of Bacterial Vaccine Manufacturing, Global Vaccines Industrial Affairs with Sanofi Group in Swiftwater, PA, where she was responsible for leading and driving manufacturing processes and building operational leadership capability, as the company provided meningococcal vaccine supplies to the U.S. and more than 68 international countries.
During her tenure with Sanofi, Dr. Wang also served as project director for Global Manufacturing Technology out of its Toronto, Canada location, head of its multiproduct manufacturing facility for the launch of the SAR34103 Biosimilar mAb, and head of its single-use technology-based facility for the commercialization of Cdiffense.
Prior to Sanofi, Dr. Wang held leadership roles within multiple organizations including Bayer HealthCare, the Schering-Plough Research Institute, ImClone Systems, and Covance Biotechnology Services.
"The role of Site Head/General Manager in our Bothell, Washington facility — AGC Biologics' global headquarters — is critical to our operations expansion and growth," said Patricio Massera, AGC Biologics chief operations officer. "Dr. Wang's expertise and experience in biologics and strong leadership skills are the perfect combination to lead the Bothell site into the future."
Dr. Wang has more than 20 years of leadership experience in the biotechnology and manufacturing industry. Most recently she served as site head of Bacterial Vaccine Manufacturing, Global Vaccines Industrial Affairs with Sanofi Group in Swiftwater, PA, where she was responsible for leading and driving manufacturing processes and building operational leadership capability, as the company provided meningococcal vaccine supplies to the U.S. and more than 68 international countries.
During her tenure with Sanofi, Dr. Wang also served as project director for Global Manufacturing Technology out of its Toronto, Canada location, head of its multiproduct manufacturing facility for the launch of the SAR34103 Biosimilar mAb, and head of its single-use technology-based facility for the commercialization of Cdiffense.
Prior to Sanofi, Dr. Wang held leadership roles within multiple organizations including Bayer HealthCare, the Schering-Plough Research Institute, ImClone Systems, and Covance Biotechnology Services.
"The role of Site Head/General Manager in our Bothell, Washington facility — AGC Biologics' global headquarters — is critical to our operations expansion and growth," said Patricio Massera, AGC Biologics chief operations officer. "Dr. Wang's expertise and experience in biologics and strong leadership skills are the perfect combination to lead the Bothell site into the future."
